Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06633978
- Status
- Recruiting
Conditions
- Aging
- MCI
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- MediTrain — DEVICEParticipants will engage with a digital meditation app for 30m/day for 6wks. MediTrain is a tablet-based, meditation-inspired, cognitive training game aimed at improving self-regulation of internal attention and distractions. It was developed in collaboration with meditation thought-leader Jack Kornfield, and Zynga, a world-class video game company. It was created to make benefits of concentrative meditation more easily accessible to anyone, including complete novices. This is achieved by creating a game that yields quantifiable and attainable goals, provides feedback, and includes an adaptive algorithm to gradually increase difficulty as users improve.
- wrist worn multi-sensor watches — DEVICEStress and sleep data will be recorded at home throughout the intervention using FDA-approved wrist worn multi-sensor watches.
- Sleep monitor — DEVICESleep Profiler devices are FDA-cleared reduced-montage EEG recording devices that will be used in accordance with its FDA clearance. They are completely non-invasive and are designed to be comfortable enough to wear all night without interfering with normal sleep. These devices enable quality sleep recordings in the comfort of people's homes, rather than required an overnight stay at a sleep lab at UCSF.
Study Details
The goal of this proposed research is to collect pilot data to test the hypothesis that treatment with a novel form of closed-loop digital meditation (MediTrain) will lead to a greater magnitude of gains in cognitive abilities in patients with mild cognitive impairment (MCI), compared to OA without cognitive impairment, and will lead to improvements in quantitative measures of sleep.
Key Dates
- Start date
- Sep 10, 2024
- Status verified
- Feb 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: MediTrain
Primary Outcome Measure
Mean change on the Continuous Performance Task (CPT) over time [ Time Frame: baseline, immediate follow-up, and at a 6 month follow-up in a subset of participants ]
Central Contacts
- Joseph Chen, PhD415-476-2164
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 |
Find similar trials in San Francisco, CA
By research site
Related Studies
- Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli OrisPHASE4 · Not Yet Recruiting · Amir Moradi MD, MBA · Vista, California
- Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's DiseaseRecruiting · Neurobehavioral Systems, Inc. · Berkeley, California
- Using Nicotine to Reverse Age-related Auditory Processing DeficitsRecruiting · University of California, Irvine · Irvine, California
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized EldersRecruiting · University of Michigan · Orange, California